IMPLANET is an international company founded by European institutional and private investors, with headquarters near Bordeaux (FR) and a US subsidiary in Boston.
Implanet's focus is on products for the spine, knee and arthroscopy.
Implanet's flagship product, the latest generation Jazzâ„¢ implant, is designed to improve the treatment of spinal conditions requiring surgical spinal fusion. Jazzâ„¢ is protected by four groups of international patents and has 510(k) clearance from the U.S. Food and Drug Administration (FDA) as well as a CE mark.
2006
Served areaWorldwide
Headcount39
HeadquartersTechnopole Bordeaux Montesquieu Allée François Magendie, 33650 Martillac – France
19,691,801
IPOJuly 11, 2017
Stock exchange(s)Euronext Paris